|
Zoledronic Acid Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: zoledronate
Pipeline
Phase 3: 1Phase 1/2: 2
Top Sponsors
- Washington University School of Medicine1
- University of Florida1
- St. Louis University1
Indications
- Cancer3
- Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer1
- Myoepithelial Tumor1
- Rhabdoid Tumor1
- Desmoplastic Small Round Cell Tumor1
Los Angeles, California1 trial
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
University of California - Los Angeles
Phase 3
Gainesville, Florida1 trial
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
University of Florida
Phase 1/2
Westwood, Kansas1 trial
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
The University of Kansas Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.